ATI RN
ATI Gastrointestinal System Test
1. Type A chronic gastritis can be distinguished from type B by its ability to:
- A. Cause atrophy of the parietal cells.
- B. Affect only the antrum of the stomach.
- C. Thin the lining of the stomach walls.
- D. Decrease gastric secretions.
Correct answer: A
Rationale: Type A chronic gastritis can cause atrophy of the parietal cells, which is a distinguishing feature from type B.
2. Which of the following tests is most commonly used to diagnose cholecystitis?
- A. Abdominal CT scan
- B. Abdominal ultrasound
- C. Barium swallow
- D. Endoscopy
Correct answer: B
Rationale: An abdominal ultrasound is the most commonly used test to diagnose cholecystitis.
3. A Penrose drain is in place on the first postoperative day following a cholecystectomy. Serosanguineous drainage is noted on the dressing covering the drain. Which nursing intervention is most appropriate?
- A. Notify the physician.
- B. Change the dressing.
- C. Circle the amount on the dressing with a pen.
- D. Continue to monitor the drainage.
Correct answer: B
Rationale: Serosanguineous drainage with a small amount of bile is expected from the Penrose drain for the first 24 hours. Drainage then decreases, and the drain is removed usually within 48 hours. The nurse does not need to notify the physician. A sterile dressing covers the site and should be changed to prevent infection and skin excoriation.
4. Risk factors for the development of hiatal hernias are those that lead to increased abdominal pressure. Which of the following complications DOES NOT cause increased abdominal pressure?
- A. Obesity
- B. Volvulus
- C. Constipation
- D. Intestinal obstruction
Correct answer: B
Rationale: Obesity, constipation, and intestinal obstruction can all lead to increased abdominal pressure, which in turn can cause a hiatal hernia.
5. Which of the following best describes the method of action of medications, such as ranitidine (Zantac), which are used in the treatment of peptic ulcer disease?
- A. Neutralize acid
- B. Reduce acid secretions
- C. Stimulate gastrin release
- D. Protect the mucosal barrier
Correct answer: B
Rationale: Medications like ranitidine (Zantac) are H2 receptor antagonists that reduce acid secretions in the stomach, helping to treat peptic ulcer disease.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access